NCT06469580

Brief Summary

The objective of the study is to evaluate the role of neonatologist-performed lung ultrasound (NPLUS) after weaning from invasive mechanical ventilation and extubation. Our aim is to study the diagnostic accuracy of NPLUS and investigate whether LUS leads to earlier actions before clinical deterioration and hence prevents extubation failure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

11 months

First QC Date

May 21, 2024

Last Update Submit

June 17, 2024

Conditions

Keywords

neonatologist performed lung ultrasoundextubation failureneonatesconsolidation

Outcome Measures

Primary Outcomes (1)

  • Reintubation rate (within 72 hours after extubation)

    within 72 hours after extubation

Secondary Outcomes (12)

  • Mode of respiratory support

    within 72 hours after extubation

  • Respiratory settings- FiO2

    within 72 hours after extubation

  • Respiratory settings- PEEP

    within 72 hours after extubation

  • SpO2/FiO2 ratio

    every hour during 72 hours after extubation

  • pH from capillary blood gas analysis

    within 72 hours after extubation

  • +7 more secondary outcomes

Study Arms (2)

NPLUS group

EXPERIMENTAL

In the NPLUS group (intervention group) lung ultrasound is performed at time point T0 (prior to extubation), T1 (2-4 hours post extubation) and time point T2 (16-24 h) post extubation.

Other: NPLUS (neonatologist performed lung ultrasound)

control group

NO INTERVENTION

Includes routine care in the control group in case of clinical (respiratory) deterioration which is optional chest x-ray or NPLUS at any time point after extubation indicated by the clinician in charge. There are no study-specific measures in the control group.

Interventions

NPLUS is conducted with an ultrasound scanner using a high-frequency (12-15 MHz) linear transducer probe (scanning depth approximately 4-5 cm). The neonate is placed in a supine position. The anterior, lateral and posterior chest areas are scanned using the presets "lung" or "small parts". Landmarks are the anterior and posterior axillary line (longitudinal) on each hemithorax. A sequential scan from right to left, anterior to posterior is performed. (6 lung areas). In the study NPLUS is performed to quantify the lung ultrasound score at time points T0, T1 and T2. Sequences of 3-5 seconds are saved and assessed according to the lung ultrasound score adapted by Rodriguez-Fanjul et al. (0- to 3 point score for each area, resulting in a total score ranging from 0 to 18). To ensure inter-observer reliability the anonymous video sequences are then rated by two independent neonatologists.

NPLUS group

Eligibility Criteria

Age1 Minute - 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All preterm and full-term neonates receiving invasive mechanical ventilation at the Division of Neonatology of the Medical University of Graz AND
  • Written informed consent was obtained from parents prior to extubation

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pediatrics, Division of Neonatology, Medical University of Graz

Graz, Styria, 8036, Austria

RECRUITING

MeSH Terms

Conditions

Infant, Newborn, Diseases

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Bernhard Schwaberger, MD PhD

    Division of Neonatology, Medical University of Graz, Austria

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bernhard Schwaberger, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2024

First Posted

June 21, 2024

Study Start

June 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

June 21, 2024

Record last verified: 2024-06

Locations